Clinical Trials Logo

Clinical Trial Summary

The Hematology Service provides hematology consultations for patients at the Clinical Center and participates in the training of hematology fellows. Patients with a broad range of hematologic disorders must be available in order for the senior staff of the Service to maintain clinical expertise and to provide the breadth of experience necessary for the fellowship program. The purpose of this protocol is to meet these needs by allowing the Hematology Service to see patients with a spectrum of hematologic diseases not studied on existing research protocols at the NIH. These patients will be evaluated over the course of several outpatient visits and returned to the care of their referring physicians.This study was developed to evaluate and possibly treat patients with blood disorders. The Hematology Service of the National Institutes of Health is responsible for the care of patients participating in research studies. In addition the Hematology Service also provides consultation for small groups of patients with blood disorders that have not been diagnosed or that may need special testing.

This study will also provide doctors at the NIH the opportunity to learn more about a wide range of blood disorders and conditions. Patients participating in this study will be evaluated over the course of several outpatient visits and will continue to be cared for by their regular physician.


Clinical Trial Description

The Hematology Service provides hematology consultations for patients at the Clinical Center and participates in the training of hematology fellows. Patients with a broad range of hematologic disorders must be available in order for the senior staff of the Service to maintain clinical expertise and to provide the breadth of experience necessary for the fellowship program. The purpose of this protocol is to meet these needs by allowing the Hematology Service to see patients with a spectrum of hematologic diseases not studied on existing research protocols at the NIH. These patients will be evaluated over the course of several outpatient visits and returned to the care of their referring physicians. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00001715
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact
Status Completed
Phase
Start date April 21, 1998
Completion date August 23, 2017

See also
  Status Clinical Trial Phase
Completed NCT00484848 - Functional Evaluation of Two Types of Totally Implanted Venous Ports N/A
Completed NCT00507533 - Early Application of CPAP in Hematologic Phase 4
Completed NCT00168090 - Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD) Phase 4
Recruiting NCT03920735 - Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail Patients
Completed NCT00001749 - Medical Treatment for Diamond Blackfan Anemia Phase 2
Completed NCT03013439 - Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) Phase 1
Completed NCT00994136 - Safety of Catheter Lock With or Without Heparin in Implanted Central Venous Catheters Phase 4
Completed NCT01178177 - Radiologic Features of Invasive Pulmonary Aspergillosis N/A
Completed NCT00111215 - Treatment and Management of Women With Bleeding Disorders N/A
Completed NCT00586521 - BAY14-2222 Prophylaxis and Joint Function Improvement (Adults) Phase 4
Completed NCT00782470 - Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A N/A
Completed NCT01426295 - Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital Phase 2
Completed NCT01220011 - Randomized Controlled Trial Comparing a Conservative Management and Laser Surgery N/A